Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Dialysis
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
SAfety of Regional Citrate Anticoagulation (SARCA Study)
Details : Dialysis is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Acute Kidney Injury.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
April 21, 2022
Lead Product(s) : Dialysis
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable